Cell Growth Signaling in Cancer Development

癌症发展中的细胞生长信号传导

基本信息

项目摘要

DESCRIPTION (provided by applicant): The mTOR pathway is a signaling system that regulates growth and metabolism in response to the nutritional state of the organism. Increasing evidence indicates that the pathway is commonly deregulated in cancer, neurodegeneration, and diabetes, and also plays a major role in the aging process. The large mTOR protein kinase is the target of the drug rapamycin and the catalytic subunit of two multi-protein complexes, mTOR Complex 1 (mTORC1) and 2 (mTORC2) that nucleate distinct branches of the mTOR pathway and respond to different upstream signals. mTORC1 responds to a diverse set of stimuli, such as growth factors, nutrients, and stresses, and regulates many anabolic and catabolic processes, including protein and lipid synthesis and autophagy. Recently, we discovered that mTORC1 regulates, in a non-cell autonomous fashion, the self-renewal of intestinal stem cells (ISCs) in response to caloric restriction (CR). mTORC1 acts in Paneth cells, which constitute the niche for ISCs and are located at the base of intestinal crypts. CR is a reduction in caloric restriction in the absence of malnutrition and has very interesting effects in mice, such as decreasing tumor growth and increasing lifespan. The mechanisms through which CR functions are not well understood in mammals. The broad goals of our work are to arrive at a mechanistic understanding of how mTORC1 senses the CR state in Paneth cells, how its activity modulates Paneth cell function to regulate ISCs, and to determine the implications of our work for understanding the effects of CR on tumorigenesis. The specific aims of our proposed work are to: identify the mTORC1-dependent effectors through which CR acts in Paneth cells to promote ISC self renewal (Aim 1); determine the factors Paneth cells use to modulate intestinal ISC renewal in response to CR (Aim 2); and determine how CR and mTORC1 activity in Paneth cells regulate intestinal tumorigenesis (Aim 3). We will accomplish our goals with a multi- disciplinary approach that uses the tools of biochemistry, molecular biology, and mouse engineering. Our results are likely to have important consequences for our understanding of the clinically important mTOR pathway. Moreover, the signaling mechanisms we uncover may serve in the future as targets for the development of therapies that mimic some of the beneficial effects of CR.
描述(由申请人提供):mTOR通路是一种信号传导系统,可响应生物体的营养状态调节生长和代谢。越来越多的证据表明,该途径通常在癌症,神经退行性疾病和糖尿病中失调,并且在衰老过程中也起着重要作用。大的mTOR蛋白激酶是药物雷帕霉素的靶点,也是两种多蛋白复合物mTOR复合物1(mTORC 1)和2(mTORC 2)的催化亚基,它们使mTOR通路的不同分支成核并响应不同的上游信号。mTORC 1响应于多种刺激,如生长因子、营养素和应激,并调节许多合成代谢和分解代谢过程,包括蛋白质和脂质合成以及自噬。最近,我们发现mTORC 1以非细胞自主的方式调节肠干细胞(ISCs)对热量限制(CR)的自我更新。mTORC 1在潘氏细胞中起作用,潘氏细胞构成了ISC的生态位,位于肠隐窝的底部。CR是在没有营养不良的情况下减少热量限制, 小鼠,如减少肿瘤生长和增加寿命。哺乳动物中CR功能的机制尚不清楚。我们工作的广泛目标是从机制上理解mTORC 1如何感知Paneth细胞中的CR状态,其活性如何调节Paneth细胞功能以调节ISCs,并确定我们的工作对理解CR对肿瘤发生的影响的意义。 我们提出的工作的具体目标是:确定mTORC 1依赖性效应,通过CR在潘氏细胞中起作用,以促进ISC自我更新(目标1);确定潘氏细胞用于调节肠道ISC更新的因素,以响应CR(目标2);并确定潘氏细胞中CR和mTORC 1活性如何调节肠道肿瘤发生(目标3)。我们将通过生物化学、分子生物学和小鼠工程学的多学科方法来实现我们的目标。我们的研究结果可能对我们理解临床上重要的mTOR通路产生重要影响。此外,我们发现的信号传导机制可能在未来作为模拟CR的一些有益作用的治疗方法的发展目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David M. Sabatini其他文献

The TORC1 pathway to protein destruction
TORC1 途径导致蛋白质降解
  • DOI:
    10.1038/nature18919
  • 发表时间:
    2016-07-27
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Lynne Chantranupong;David M. Sabatini
  • 通讯作者:
    David M. Sabatini
Amino acids and KLHL22 do not activate mTORC1 via DEPDC5 degradation
氨基酸和 KLHL22 不会通过 DEPDC5 降解来激活 mTORC1
  • DOI:
    10.1038/s41586-024-07974-0
  • 发表时间:
    2025-01-08
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Max L. Valenstein;Pranav V. Lalgudi;Jibril F. Kedir;Kendall J. Condon;Anna Platzek;Daniel G. Freund;Martin S. Taylor;Yunhan Xu;Raghu R. Chivukula;David M. Sabatini
  • 通讯作者:
    David M. Sabatini
Immunophilins and nervous system
免疫亲和素与神经系统
  • DOI:
    10.1038/nm0195-32
  • 发表时间:
    1995-01-01
  • 期刊:
  • 影响因子:
    50.000
  • 作者:
    Solomon H. Snyder;David M. Sabatini
  • 通讯作者:
    David M. Sabatini
Dietary modifications for enhanced cancer therapy
用于增强癌症治疗的饮食调整
  • DOI:
    10.1038/s41586-020-2124-0
  • 发表时间:
    2020-03-25
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    Naama Kanarek;Boryana Petrova;David M. Sabatini
  • 通讯作者:
    David M. Sabatini
MIT Open Access Articles Characterization of Torin2, an ATP-Competitive Inhibitor of mTOR, ATM, and ATR
麻省理工学院开放获取文章 Torin2(一种 mTOR、ATM 和 ATR 的 ATP 竞争性抑制剂)的表征
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Qingsong Liu;Chunxiao Xu;Sivapriya Kirubakaran;Xin Zhang;W. Hur;Yan Liu;Nicholas Kwiatkowski;Jinhua Wang;K. Westover;Peng Gao;D. Ercan;M. Niepel;Carson C. Thoreen;S. A. Kang;M. Patricelli;Yuchuan Wang;T. Tupper;Abigail Altabef;Hidemasa Kawamura;Kathryn D Held;Danny M. Chou;Stephen J. Elledge;P. Janne;Kwok;David M. Sabatini;Nathanael S. Gray
  • 通讯作者:
    Nathanael S. Gray

David M. Sabatini的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David M. Sabatini', 18)}}的其他基金

Impact of aging on intestinal tumorigenesis
衰老对肠道肿瘤发生的影响
  • 批准号:
    9203123
  • 财政年份:
    2016
  • 资助金额:
    $ 40.26万
  • 项目类别:
Novel Components of the mTORC1 and mTORC2 Pathways
mTORC1 和 mTORC2 通路的新成分
  • 批准号:
    9042919
  • 财政年份:
    2015
  • 资助金额:
    $ 40.26万
  • 项目类别:
Elucidating a mechanism of mTORC1 activation independent of amino acids signaling
阐明独立于氨基酸信号传导的 mTORC1 激活机制
  • 批准号:
    8550755
  • 财政年份:
    2012
  • 资助金额:
    $ 40.26万
  • 项目类别:
Inhibitors of serine biosynthesis
丝氨酸生物合成抑制剂
  • 批准号:
    8460831
  • 财政年份:
    2012
  • 资助金额:
    $ 40.26万
  • 项目类别:
Elucidating a mechanism of mTORC1 activation independent of amino acids signaling
阐明独立于氨基酸信号传导的 mTORC1 激活机制
  • 批准号:
    8443550
  • 财政年份:
    2012
  • 资助金额:
    $ 40.26万
  • 项目类别:
Inhibitors of serine biosynthesis
丝氨酸生物合成抑制剂
  • 批准号:
    8328004
  • 财政年份:
    2012
  • 资助金额:
    $ 40.26万
  • 项目类别:
Cell Growth Signaling in Cancer Development
癌症发展中的细胞生长信号传导
  • 批准号:
    7759621
  • 财政年份:
    2008
  • 资助金额:
    $ 40.26万
  • 项目类别:
Cell Growth Signaling in Cancer Development
癌症发展中的细胞生长信号传导
  • 批准号:
    8434396
  • 财政年份:
    2008
  • 资助金额:
    $ 40.26万
  • 项目类别:
Cell Growth Signaling in Cancer Development
癌症发展中的细胞生长信号传导
  • 批准号:
    7610894
  • 财政年份:
    2008
  • 资助金额:
    $ 40.26万
  • 项目类别:
Cell Growth Signaling in Cancer Development
癌症发展中的细胞生长信号传导
  • 批准号:
    7464742
  • 财政年份:
    2008
  • 资助金额:
    $ 40.26万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了